Linezolid Krka

Linezolid, the active ingredient in Linezolid Krka, is an oxazolidinone presented as an injection for intravenous use. It treats serious Gram‑positive bacterial infections such as skin and soft‑tissue infections and both community‑acquired and nosocomial pneumonia in adult patients. GNH USA supplies Linezolid Krka as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Linezolid is an oxazolidinone antibiotic indicated for infections caused by susceptible Gram‑positive bacteria. - Skin and soft tissue infections: effective against methicillin‑resistant Staphylococcus aureus and other resistant strains. - Community‑acquired and nosocomial pneumonia: used when first‑line agents are unsuitable or resistance is present. - Complicated Gram‑positive infections: includes bacteremia, endocarditis and osteomyelitis caused by susceptible organisms.

Adverse reactions may occur with linezolid therapy and are categorized by frequency.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Diarrhea: loose stools occurring during treatment. - Headache: transient cranial discomfort. - Vomiting: occasional emesis. - Metallic taste: altered taste perception. - Rash: mild skin erythema.

Serious or Rare Side Effects: - Thrombocytopenia: significant drop in platelet count requiring monitoring. - Peripheral neuropathy: nerve damage presenting as tingling or numbness. - Serotonin syndrome: risk when combined with serotonergic agents. - Lactic acidosis: rare metabolic disturbance. - Optic neuropathy: vision changes that may be irreversible. - Severe hypersensitivity: anaphylactic reactions requiring immediate care.

Before initiating linezolid, clinicians should consider several safety measures. - Monitor blood counts: perform regular CBC to detect thrombocytopenia. - Assess renal function: adjust therapy if renal impairment is present. - Evaluate serotonergic medication use: avoid concomitant SSRIs, SNRIs, or MAO inhibitors. - Use caution in hepatic impairment: liver dysfunction may affect drug clearance. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Linezolid may interact with other medicines, requiring attention to the level of risk.

Major Interactions (Avoid): - Serotonergic agents: SSRIs, SNRIs, MAO inhibitors can precipitate serotonin syndrome. - Rifampin: strong enzyme inducer that reduces linezolid plasma concentrations. - MAO inhibitors: increase risk of hypertensive crisis.

Moderate Interactions (Monitor Closely): - NSAIDs: may increase bleeding tendency when combined with linezolid. - Warfarin: potential alteration of INR values. - Antacids containing magnesium or aluminum: may affect absorption if given simultaneously.